SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-089665
Filing Date
2023-11-22
Accepted
2023-11-22 17:28:59
Documents
141
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_bimiinter.htm   iXBRL 10-Q 1351321
2 CERTIFICATION f10q0623ex31-1_bimiintern.htm EX-31.1 10746
3 CERTIFICATION f10q0623ex31-2_bimiintern.htm EX-31.2 11393
4 CERTIFICATION f10q0623ex32-1_bimiintern.htm EX-32.1 4390
5 CERTIFICATION f10q0623ex32-2_bimiintern.htm EX-32.2 5313
  Complete submission text file 0001213900-23-089665.txt   10925182

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bimi-20230630.xsd EX-101.SCH 162846
7 XBRL CALCULATION FILE bimi-20230630_cal.xml EX-101.CAL 70741
8 XBRL DEFINITION FILE bimi-20230630_def.xml EX-101.DEF 621306
9 XBRL LABEL FILE bimi-20230630_lab.xml EX-101.LAB 1014938
10 XBRL PRESENTATION FILE bimi-20230630_pre.xml EX-101.PRE 643239
135 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_bimiinter_htm.xml XML 1356908
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34890 | Film No.: 231434562
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries